68Ga-DOTATATE imaging is commonly used for the detection of metastatic disease in neuroendocrine tumors. We present a case of a 69-year-old woman postsurgery for lung carcinoid tumor in which sequential follow-up 68Ga-DOTATATE PET/CT studies identified focal hepatic uptake that was presumed to represent a liver metastasis. However, correlative imaging with MRI revealed a focal fatty sparing of the liver composed of benign hepatic parenchyma at that area accompanied with diffuse liver steatosis in the background of the “pseudolesion.” This report demonstrates a potential “false-positive” hepatic finding that can strikingly mimic a metastasis in neuroendocrine tumor imaging.
From the *Institute of Nuclear Medicine and Molecular Imaging
Departments of †Radiology
‡Oncology, Soroka University Medical Center, Affiliated to Ben Gurion University of the Negev Faculty of Health Sciences, Beer-Sheva, Israel.
Received for publication March 19, 2019; revision accepted June 9, 2019.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Sophie Lantsberg, MD, Institute of Nuclear Medicine and Molecular Imaging, Soroka University Medical Center, POB 151, Beer-Sheva, Israel. E-mail: SophieL@clalit.org.il; or Nir Hod, MHA, MD, Institute of Nuclear Medicine and Molecular Imaging, Soroka University Medical Center, POB 151, Beer-Sheva, Israel. E-mail: email@example.com.
Online date: July 25, 2019